A health activist and blood cancer survivor, Alicia C. Staley, wrote an article yesterday about the shortage of the anti-leukemia drug, Cytarabine.  I wanted to share part of what she with you here:

Alicia C. StaleyCytarabine Shortage Impacting AML Patients

Over the past few days, I’ve heard quite a bit about a shortage of the chemotherapy drug Cytarabine. Cytarabine is used primarily to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In some cases, it’s used to treat some lymphomas. Unfortunately, this shortage started last fall and continues to get worse. This is a eye-opening case on how medications are made and distributed across the US…

You can read more of Alicia’s thoughts by going to:  WEGO Health/Cytarabine Shortage.

In addition, Alicia has provided the following links to help you learn more about the shortage:

Cytarabine Crisis: Leukemia Drug Shortage Affecting Many Hospitals

Chemotherapy Drug shortage threatens Leukemia treatment in children

For a doctor’s perspective, check out today’s opinion piece in the Washington Post written by Dr. Hagop Kantarjian of the MD Andersen Center

This is scary stuff!  Imagine not being able to access the chemotherapy drugs you need when it comes time to start your next therapy cycle.  It could literally mean life or death!

Feel good, keep smiling and try not to think about how vulnerable we all are to the whims of drug and insurance companies!  Pat

2 thoughts on “Alarming Information About Leukemia Drug Shortage

  1. Pat – Thanks for including this information. I'm hoping we learn more about this drug shortage in the days ahead. Take care! Alicia

Leave a Reply